Please try another search
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. The company operates through Pharmaceutical Industry; Building Materials Industry; and Real Estate Industry segments. It offers human insulin raw materials and injection, insulin glargine raw materials and injection, insulin aspart API and injection, Zhennaoning capsules, and diabetes-related medical devices. Further, it provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system. It offers building materials.Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.
Name | Age | Since | Title |
---|---|---|---|
Junye Wang | - | 2014 | Chairman of the Supervisory Board |
Wenhai Zhang | 48 | - | Deputy GM & Director |
Sheng Leng Chun | 48 | 2014 | Chairman & GM |
Guodong Zhang | - | - | Deputy GM & Director |
Fu Bo Cao | 53 | 2014 | Supervisor |
Yan Bi | 56 | - | Independent Director |
Qingxia He | 44 | - | Employee Representative Supervisor |
Jiahong Li | 34 | - | Director |
Wei Wang | 38 | - | Director |
Anshen Ju | 38 | - | Director |
Dai Xu | 55 | - | Independent Director |
Li Xu | 55 | - | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review